PainReform Ltd
PRFX2.960USD
-0.059-1.94%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
5.96MMarket Cap
0.07P/E TTM
More Details of PainReform Ltd Company
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PainReform Ltd Info
Ticker SymbolPRFX
Company namePainReform Ltd
IPO dateSep 01, 2020
CEOHadar (Ilan)
Number of employees2
Security typeOrdinary Share
Fiscal year-endSep 01
Address65 Yigal Alon St.
CityTEL AVIV-YAFO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code6744316
Phone97237177051
Websitehttps://painreform.com/
Ticker SymbolPRFX
IPO dateSep 01, 2020
CEOHadar (Ilan)
Company Executives of PainReform Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Dr. Ellen S. Baron
Dr. Ellen S. Baron
Independent Director
Independent Director
--
--
Mr. Augustine J. (Gus) Lawlor
Mr. Augustine J. (Gus) Lawlor
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Ilan Hadar
Mr. Ilan Hadar
Chief Executive Officer, Chief Financial Officer
Chief Executive Officer, Chief Financial Officer
--
--
Dr. Eli Hazum
Dr. Eli Hazum
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Dr. Sigal Aviel
Dr. Sigal Aviel
Chief Operating Officer
Chief Operating Officer
--
--
Mrs. Rita Keynan
Mrs. Rita Keynan
Vice President - Pharmaceutical Operations
Vice President - Pharmaceutical Operations
--
--
Dr. Ehud Geller, Ph.D.
Dr. Ehud Geller, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Efi Cohen-Arazi
Mr. Efi Cohen-Arazi
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bladeranger Ltd
4.57%
Two Sigma Investments, LP
0.41%
Medica Venture Partners
0.35%
L.I.A. Pure Capital Ltd
0.27%
UBS Financial Services, Inc.
0.11%
Other
94.29%
Shareholders
Shareholders
Proportion
Bladeranger Ltd
4.57%
Two Sigma Investments, LP
0.41%
Medica Venture Partners
0.35%
L.I.A. Pure Capital Ltd
0.27%
UBS Financial Services, Inc.
0.11%
Other
94.29%
Shareholder Types
Shareholders
Proportion
Corporation
4.83%
Hedge Fund
0.41%
Private Equity
0.35%
Investment Advisor
0.12%
Other
94.29%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
15
34.44K
0.88%
-48.14K
2025Q3
15
20.01K
0.99%
-66.86K
2025Q2
22
221.75K
11.02%
-42.46K
2025Q1
21
208.02K
26.50%
+122.57K
2024Q4
19
72.04K
4.22%
+19.22K
2024Q3
16
43.23K
4.31%
+4.77K
2024Q2
16
35.44K
14.31%
+7.32K
2024Q1
15
25.67K
11.49%
-2.27K
2023Q4
17
26.00K
30.19%
+5.33K
2023Q3
18
17.50K
39.02%
-5.90K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Bladeranger Ltd
178.77K
4.57%
--
--
Apr 01, 2025
Two Sigma Investments, LP
16.19K
0.41%
+16.19K
--
Sep 30, 2025
Medica Venture Partners
13.72K
0.35%
+2.00
+0.01%
Apr 01, 2025
L.I.A. Pure Capital Ltd
10.42K
0.27%
+10.42K
--
Aug 28, 2024
UBS Financial Services, Inc.
19.00
0%
-6.07K
-99.69%
Sep 30, 2025
Osaic Holdings, Inc.
193.00
0%
--
--
Sep 30, 2025
SBI Securities Co., Ltd.
6.00
0%
--
--
Sep 30, 2025
Virtu Americas LLC
--
0%
-836.00
-100.00%
Sep 30, 2024
Geode Capital Management, L.L.C.
--
0%
-80.00
-100.00%
Oct 31, 2024
Citadel Advisors LLC
--
0%
-715.00
-100.00%
Jun 30, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Feb 03, 2026
Merger
5→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Sep 05, 2024
Merger
6→1
Date
Ex-dividend Date
Type
Ratio
Feb 03, 2026
Merger
5→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Nov 19, 2024
Merger
4→1
Sep 05, 2024
Merger
6→1
Sep 05, 2024
Merger
6→1
Sep 05, 2024
Merger
6→1
Sep 05, 2024
Merger
6→1
Jun 30, 2023
Merger
10→1
View more
